病例报告:复发性胸腔积液和被包裹的主动脉显示Erdheim-Chester病。

IF 5.9 2区 医学 Q1 IMMUNOLOGY
Frontiers in Immunology Pub Date : 2025-09-12 eCollection Date: 2025-01-01 DOI:10.3389/fimmu.2025.1585541
Tiépé Rokia Ouattara, Théo Pezel, Gwenael Lorillon, Aïcha Kante, Peggy Reiner, Aurélie Le Gal, Marine Lefèvre, Thibault Vieira, Stéphane Mouly, Abdellatif Tazi, Julien Haroche, Trecy Goncalves, Damien Sène, Jean-François Emile, Cloé Comarmond
{"title":"病例报告:复发性胸腔积液和被包裹的主动脉显示Erdheim-Chester病。","authors":"Tiépé Rokia Ouattara, Théo Pezel, Gwenael Lorillon, Aïcha Kante, Peggy Reiner, Aurélie Le Gal, Marine Lefèvre, Thibault Vieira, Stéphane Mouly, Abdellatif Tazi, Julien Haroche, Trecy Goncalves, Damien Sène, Jean-François Emile, Cloé Comarmond","doi":"10.3389/fimmu.2025.1585541","DOIUrl":null,"url":null,"abstract":"<p><p>Erdheim-Chester disease (ECD) is a rare histiocytic disorder with localized presentations or multisystem disease. Clinical presentations of ECD are usually non-specific and depends on the site of involvement. ECD can involve one or several organs. Clinical manifestations range from asymptomatic lesions to severe and life-threatening organ dysfunction. Hence, accurate and timely diagnosis is challenging given the rarity and varied presentation of ECD. The most common clinical manifestations are bone pain related to osteosclerosis, usually in the lower limbs. We report here a case with no obvious clinical manifestation of ECD preceding initial recurrent pleural effusions. The diagnosis of ECD was suggested based on pleural thickening revealed by relapsing pleural effusions combined with radiological finding of a coated aorta and slight perirenal infiltrate. Pleural biopsy revealed collagen fibrosis, and immunohistochemistry with the anti-CD163 antibody showed an important infiltration by histiocytes, strong cytoplasmic phosphorylated ERK in the lesional cells, and positive factor XIIIa staining. A cell-free DNA from peripheral blood revealed negative <i>BRAF</i> mutation and the presence of <i>MAP2K1</i> mutation, a key driver mutation in ECD. The diagnosis is often suggested based on clinic-radiological presentation but requiring histopathology to establish a final diagnosis of ECD. Plasma cell-free DNA is a promising and non-invasive tool to detect key driver mutations.</p>","PeriodicalId":12622,"journal":{"name":"Frontiers in Immunology","volume":"16 ","pages":"1585541"},"PeriodicalIF":5.9000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12463926/pdf/","citationCount":"0","resultStr":"{\"title\":\"Case Report: Relapsing pleural effusions and coated aorta revealing Erdheim-Chester disease.\",\"authors\":\"Tiépé Rokia Ouattara, Théo Pezel, Gwenael Lorillon, Aïcha Kante, Peggy Reiner, Aurélie Le Gal, Marine Lefèvre, Thibault Vieira, Stéphane Mouly, Abdellatif Tazi, Julien Haroche, Trecy Goncalves, Damien Sène, Jean-François Emile, Cloé Comarmond\",\"doi\":\"10.3389/fimmu.2025.1585541\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Erdheim-Chester disease (ECD) is a rare histiocytic disorder with localized presentations or multisystem disease. Clinical presentations of ECD are usually non-specific and depends on the site of involvement. ECD can involve one or several organs. Clinical manifestations range from asymptomatic lesions to severe and life-threatening organ dysfunction. Hence, accurate and timely diagnosis is challenging given the rarity and varied presentation of ECD. The most common clinical manifestations are bone pain related to osteosclerosis, usually in the lower limbs. We report here a case with no obvious clinical manifestation of ECD preceding initial recurrent pleural effusions. The diagnosis of ECD was suggested based on pleural thickening revealed by relapsing pleural effusions combined with radiological finding of a coated aorta and slight perirenal infiltrate. Pleural biopsy revealed collagen fibrosis, and immunohistochemistry with the anti-CD163 antibody showed an important infiltration by histiocytes, strong cytoplasmic phosphorylated ERK in the lesional cells, and positive factor XIIIa staining. A cell-free DNA from peripheral blood revealed negative <i>BRAF</i> mutation and the presence of <i>MAP2K1</i> mutation, a key driver mutation in ECD. The diagnosis is often suggested based on clinic-radiological presentation but requiring histopathology to establish a final diagnosis of ECD. Plasma cell-free DNA is a promising and non-invasive tool to detect key driver mutations.</p>\",\"PeriodicalId\":12622,\"journal\":{\"name\":\"Frontiers in Immunology\",\"volume\":\"16 \",\"pages\":\"1585541\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12463926/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fimmu.2025.1585541\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fimmu.2025.1585541","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

埃尔德海姆-切斯特病(ECD)是一种罕见的组织细胞疾病,具有局部表现或多系统疾病。ECD的临床表现通常是非特异性的,取决于受累部位。ECD可累及一个或多个器官。临床表现从无症状的病变到严重的危及生命的器官功能障碍。因此,鉴于ECD的罕见性和多样性,准确和及时的诊断是具有挑战性的。最常见的临床表现是与骨硬化有关的骨痛,通常发生在下肢。我们在此报告一例在初始复发性胸腔积液之前没有明显临床表现的ECD。根据反复胸腔积液所显示的胸膜增厚,再加上放射学上的主动脉包裹和轻微的肾周浸润,建议诊断为ECD。胸膜活检显示胶原纤维化,抗cd163抗体免疫组化显示组织细胞有重要浸润,病变细胞中有强烈的胞质磷酸化ERK,阳性因子XIIIa染色。来自外周血的无细胞DNA显示阴性BRAF突变和MAP2K1突变的存在,MAP2K1突变是ECD的关键驱动突变。诊断通常建议基于临床放射表现,但需要组织病理学来确定ECD的最终诊断。无浆细胞DNA是一种很有前途的非侵入性检测关键驱动突变的工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Case Report: Relapsing pleural effusions and coated aorta revealing Erdheim-Chester disease.

Erdheim-Chester disease (ECD) is a rare histiocytic disorder with localized presentations or multisystem disease. Clinical presentations of ECD are usually non-specific and depends on the site of involvement. ECD can involve one or several organs. Clinical manifestations range from asymptomatic lesions to severe and life-threatening organ dysfunction. Hence, accurate and timely diagnosis is challenging given the rarity and varied presentation of ECD. The most common clinical manifestations are bone pain related to osteosclerosis, usually in the lower limbs. We report here a case with no obvious clinical manifestation of ECD preceding initial recurrent pleural effusions. The diagnosis of ECD was suggested based on pleural thickening revealed by relapsing pleural effusions combined with radiological finding of a coated aorta and slight perirenal infiltrate. Pleural biopsy revealed collagen fibrosis, and immunohistochemistry with the anti-CD163 antibody showed an important infiltration by histiocytes, strong cytoplasmic phosphorylated ERK in the lesional cells, and positive factor XIIIa staining. A cell-free DNA from peripheral blood revealed negative BRAF mutation and the presence of MAP2K1 mutation, a key driver mutation in ECD. The diagnosis is often suggested based on clinic-radiological presentation but requiring histopathology to establish a final diagnosis of ECD. Plasma cell-free DNA is a promising and non-invasive tool to detect key driver mutations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.80
自引率
11.00%
发文量
7153
审稿时长
14 weeks
期刊介绍: Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信